Riskpilot← Back to searchSign inGet full accessPermedicus Aktiebolag
ABActiveOrg 5563718518Järntorget 83 3vOther education n.e.c. · NACE 8559Est. 19890 employees
Revenue 2024
SEK 15K
-54% vs 2023
EBITDA margin
-563.2%
-1340% vs 2023
Equity ratio
44.0%
Financial strength
Net profit 2024
SEK -79K
-559% vs 2023
| Revenue | SEK 15K | -54% |
| EBITDA | SEK -82K | -1340% |
| Net profit | SEK -79K | -559% |
| Total assets | SEK 1,3M | +8% |
| Equity | SEK 568K | -12% |
| Employees | 0 | — |
Legal name
Permedicus Aktiebolag
Org number
5563718518
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
6 november 1989
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Lindqvist, Per Gustav
Company purpose
Aktiebolaget ska bedriva medicinsk behandling och konsult- verksamhet samt forskning, utveckling och utbildning inom medicin, ävensom äga, förvalta och bedriva handel med värdepapper och fast egendom.
Address
Järntorget 83 3v
Email
pelle.lindqvist@ki.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 19 | 0 | 16 | 31 | 15 |
| Staff expenses | — | — | — | — | −10 |
| EBITDA | −31 | −25 | −16 | −6 | −82 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −31 | −25 | −16 | −6 | −82 |
| Net financials | 2 | 252 | 138 | −6 | 3 |
| Profit before tax | −29 | 227 | 121 | −12 | −79 |
| Tax | −0 | −44 | −25 | — | — |
| Net profit | −29 | 183 | 96 | −12 | −79 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 391 | 699 | 1 146 | 1 197 | 1 293 |
| Equity | 381 | 563 | 659 | 647 | 568 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 10 | 135 | 487 | 549 | 725 |
| Total debt | 10 | 135 | 487 | 549 | 725 |
EBITDA margin
-563.2%
This company
15.8%
Market median
-3665% vs market
20202024
Equity ratio
44.0%
This company
38.2%
Market median
+15% vs market
20202024
Return on equity
-13.9%
This company
18.4%
Market median
-176% vs market
20202024
Net profit margin
-543.0%
This company
8.1%
Market median
-6804% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
1.28×
This company
0.62×
Market median
-106% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Permedicus Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Svante Lindqvist | Deputy Board Member | 0 companies |
| Per Gustav Lindqvist | Chairman | 0 companies |
| Eva Elisabeth Epstein | Board of Directors | 0 companies |